IRIS
BRACONI, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.130
EU - Europa 7.534
AS - Asia 3.769
SA - Sud America 634
AF - Africa 194
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.009
GB - Regno Unito 1.953
RU - Federazione Russa 1.296
CN - Cina 1.216
SG - Singapore 1.215
IT - Italia 1.102
IE - Irlanda 794
DE - Germania 565
BR - Brasile 532
SE - Svezia 486
UA - Ucraina 429
VN - Vietnam 405
FR - Francia 395
HK - Hong Kong 270
FI - Finlandia 194
KR - Corea 174
IN - India 145
ZA - Sudafrica 76
TR - Turchia 65
ES - Italia 59
CA - Canada 58
BD - Bangladesh 48
AR - Argentina 47
BE - Belgio 39
CI - Costa d'Avorio 39
NL - Olanda 39
MX - Messico 34
PL - Polonia 34
CZ - Repubblica Ceca 33
NG - Nigeria 31
JP - Giappone 30
IQ - Iraq 29
IR - Iran 24
AT - Austria 22
ID - Indonesia 22
PK - Pakistan 19
PT - Portogallo 14
AE - Emirati Arabi Uniti 13
EE - Estonia 12
LT - Lituania 12
AU - Australia 11
EC - Ecuador 11
KE - Kenya 11
CH - Svizzera 10
CO - Colombia 10
JO - Giordania 10
UZ - Uzbekistan 10
VE - Venezuela 10
AZ - Azerbaigian 9
CR - Costa Rica 9
SA - Arabia Saudita 9
TN - Tunisia 9
BO - Bolivia 8
EG - Egitto 8
SK - Slovacchia (Repubblica Slovacca) 8
EU - Europa 7
PH - Filippine 7
MA - Marocco 6
NP - Nepal 6
PY - Paraguay 6
AL - Albania 5
AM - Armenia 5
CL - Cile 5
JM - Giamaica 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
RO - Romania 5
DO - Repubblica Dominicana 4
GR - Grecia 4
HU - Ungheria 4
IL - Israele 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BG - Bulgaria 3
DK - Danimarca 3
ET - Etiopia 3
KW - Kuwait 3
KZ - Kazakistan 3
OM - Oman 3
PE - Perù 3
BY - Bielorussia 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
MT - Malta 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SO - Somalia 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 21.273
Salva come PNG Salva come JPEG
Città #
Southend 1.712
Dallas 1.053
Fairfield 878
Dublin 784
Menlo Park 730
Singapore 726
Ashburn 610
Chandler 554
Woodbridge 400
Siena 369
Moscow 361
Jacksonville 347
Santa Clara 341
Wilmington 332
Houston 303
Seattle 303
San Jose 297
Cambridge 276
Beijing 266
Hong Kong 257
Ann Arbor 238
Hefei 202
Seoul 168
Princeton 164
Los Angeles 137
Milan 137
The Dalles 122
Ho Chi Minh City 120
Nanjing 116
New York 115
Helsinki 111
Council Bluffs 104
Florence 99
Hanoi 83
Lauterbourg 83
Boardman 75
Munich 71
Johannesburg 66
San Mateo 59
Shanghai 51
São Paulo 51
Buffalo 48
Bengaluru 47
Dearborn 47
London 46
San Diego 46
Fremont 45
Nanchang 43
Abidjan 39
Izmir 38
Brussels 37
Orem 36
Columbus 35
Lancaster 34
Shenyang 32
Rome 31
Frankfurt am Main 30
Abuja 29
Málaga 28
Haiphong 27
Tianjin 25
Warsaw 25
Da Nang 24
Stockholm 24
Tokyo 23
Hebei 22
Changsha 21
Chicago 21
Redwood City 21
Brno 20
Phoenix 20
Amsterdam 19
Atlanta 19
Denver 19
Norwalk 19
Chennai 18
Jiaxing 18
Montreal 17
Redondo Beach 17
Vienna 17
Zhengzhou 17
Brooklyn 16
Dong Ket 16
Kunming 16
Rio de Janeiro 16
Belo Horizonte 15
Hangzhou 15
Manchester 15
Poplar 15
Renton 15
Turku 15
San Francisco 14
Toronto 14
Düsseldorf 13
Nuremberg 13
Jakarta 12
Monteroni D'arbia 12
Mumbai 12
Washington 12
Brasília 11
Totale 14.682
Salva come PNG Salva come JPEG
Nome #
Chondroptosis in alkaptonuric cartilage 490
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 484
Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient 405
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases 403
Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria 402
Biochemical and proteomic characterization of alkaptonuric chondrocytes 384
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 375
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 368
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria 366
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 357
Beer promotes differentiation and mineralization of human osteoblastic cells: Role of silicon 353
Alkaptonuria is a novel human secondary amyloidogenic disease 348
Angiogenesis in alkaptonuria 341
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project 338
Diagnosis of secondary amyloidosis in alkaptonuria 303
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. 300
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure 300
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 298
Yield Determination of Bioethanol Production of Saccharomyces Cerevisiae Metabolic Process by Mathematical Modelling and In-Vivo 13C-NMR 291
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 288
Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria 288
Amyloidosis in alkaptonuria 286
Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins 284
An Introduction to Personalized Nutrition 284
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes 279
Wild-type wine Saccharomyces cerevisiae as a tool to evaluate the effects on eukaryotic life of locally used herbicides 272
Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease 271
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease 270
Secondary amyloidosis in an alkaptonuric aortic valve 267
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis 265
Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria 265
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis 264
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain 262
Antibacterial activity of grape extracts towards cagA positive and cagA negative Helicobacter pylori clinical isolates 262
Machine learning application for patient stratification and phenotype/genotype investigation in a rare disease 261
Oxidative stress and mechanisms of ochronosis in alkaptonuria 260
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria 256
Saccharomyces cerevisiae as a Tool to Evaluate the Effects of Herbicides on Eukaryotic Life 252
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial 249
Helicobacter pylori: immunoproteomics related to different pathologies 244
Mapping phosphoproteins in Neisseria meningitidis serogroup A 240
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure 236
Oxidative damage mediated by herbicides on yeast cells 236
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain 233
Suitability of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment 232
Foodomics for human health: current status and perspectives 231
Alkaptonuria 230
Effects of selenium on oxidative damage and antioxidant enzymes of eukaryotic cells: wine Saccharomyces cerevisiae 229
Redox proteomics gives insights into the role of oxidative stress in alkaptonuria 227
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model 221
Metabolic response to exogenous ethanol in yeast: an in vivo NMR and mathematical modelling approach 221
In vivo NMR study of yeast fermentative metabolism in the presence of ferric irons 219
Supportive use of cyclodextrins as decontamination agents for herbicides 209
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria 207
Personalized nutrition and omics technologies 203
Oxidative damage induced by herbicides is mediated by thiol oxidation and hydroperoxides production 201
Post-genomics of bone metabolic dysfunctions and neoplasias 200
Membrane Skeletal Protein S-Glutathionylation in Human Red Blood Cells as Index of Oxidative Stress 199
Cell and tissue models of alkaptonuria 199
Saccharomyces cerevisiae as a model in ecotoxicological studies: a post-genomics perspective 198
Expanding the proteome database of Meningococcus A 196
Omics-based technologies for food authentication and traceability 195
Surfome analysis of a wild-type wine Saccharomyces cerevisiae strain 190
Omics Perspectives in Food Science 190
Postgenomics of Neisseria meningitidis: An update 188
Bacterial post-genomics approaches for vaccines development 183
Linking protein oxidation to environmental pollutants: redox proteomic approaches 174
Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform 172
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies 169
Post-genomics and skin inflammation 168
The therapy for Helicobacter pylori eradication 167
Sub-lethal ethanol exposure enhances viability and ethanol production in Saccharomyces cerevisiae 162
Rubus ulmifolius Leaf Extract Inhibits Proliferation of Murine Myeloma Cells 159
Diagnosis of Helicobacter pylori infection 157
Omics and rare diseases: challenges, applications, and future perspectives 152
Postgenomics of Neisseria meningitidis for vaccines development 149
Leveraging proteomics in orphan disease research: pitfalls and potential 149
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria 148
The analysis of Neisseria meningitidis proteomes: reference maps and their applications 143
Identification of Helicobacter pylori proteins involved in metronidazole resistance by comparative proteomic analysis 136
Post-genomics of Neisseria meningitidis: an update 130
Proteomics in plant research 126
Survey on the recent advances in 4-Hydroxyphenylpyruvate Dioxygenase (HPPD) inhibition by diketone and triketone derivatives and congeneric compounds: structural analysis of HPPD/inhibitor complexes and structure-activity relationship considerations 126
Helicobacter pylori infection and extra-digestive diseases 124
Models of rare diseases 122
Helicobacter pylori VacA and CagA virulence factors 121
Kinetics of different processes in human ANP amyloid formation 121
Novel identification of expressed genes and functional classification of hypothetical proteins from Neisseria meningitidis serogroup A 119
Subclinical ochronosis features in alkaptonuria: a cross-sectional study 117
A Comprehensive In Vitro and In Silico Approach for Targeting 4-Hydroxyphenyl Pyruvate Dioxygenase: Towards New Therapeutics for Alkaptonuria 79
Uncovering proteomic and biochemical alterations in plasma from Lesch–Nyhan disease patients 61
Destabilization of Helix III Initiates Early Serum Amyloid A Misfolding by Exposing Its Amyloidogenic Core 33
Integrated Clinomics and Molecular Dynamics Simulation Approaches Reveal the SAA1.1 Allele as a Biomarker in Alkaptonuria Disease Severity 7
Totale 21.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/20221.586 139 173 118 121 77 62 83 60 86 193 161 313
2022/20231.822 117 188 236 249 167 340 61 155 167 43 54 45
2023/20241.357 47 30 126 65 66 361 427 38 5 14 48 130
2024/20252.657 64 136 328 136 295 132 128 180 258 115 261 624
2025/20266.462 453 884 886 862 1.364 253 771 172 254 352 198 13
Totale 21.539